Therapy-induced senescence - an induced synthetic lethality in liver cancer?

Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):135-136. doi: 10.1038/s41575-020-0262-3.

Katharina Wolter^{1

2}, Lars Zender^{3

4

5}

¹ Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen, Germany.
² Cluster of Excellence 'Image Guided and Functionally Instructed Tumor Therapies' (iFIT), Eberhard-Karls University of Tübingen, Tübingen, Germany.
³ Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen, Germany. Lars.Zender@med.uni-tuebingen.de.
⁴ Cluster of Excellence 'Image Guided and Functionally Instructed Tumor Therapies' (iFIT), Eberhard-Karls University of Tübingen, Tübingen, Germany. Lars.Zender@med.uni-tuebingen.de.
⁵ German Consortium for Translational Cancer Research (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany. Lars.Zender@med.uni-tuebingen.de.

No abstract available

Publication types